PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
37.12%
Some net income increase while AVGO is negative at -21.38%. John Neff would see a short-term edge over the struggling competitor.
-1.26%
Negative yoy D&A while AVGO is 2.50%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
120.83%
Some yoy growth while AVGO is negative at -100.00%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
17.19%
SBC growth well above AVGO's 21.43%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-153.88%
Negative yoy working capital usage while AVGO is 100.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-129.40%
AR is negative yoy while AVGO is 781.82%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-37.36%
Both reduce yoy inventory, with AVGO at -163.64%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-209.91%
Both negative yoy AP, with AVGO at -383.33%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-292.59%
Both reduce yoy usage, with AVGO at -9.52%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
99.15%
Well above AVGO's 99.50%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-66.82%
Both yoy CFO lines are negative, with AVGO at -13.95%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
12.50%
CapEx growth well above AVGO's 8.22%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
18.91%
Purchases growth of 18.91% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
9.86%
Liquidation growth of 9.86% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
111.64%
We have mild expansions while AVGO is negative at -2.70%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
241.35%
We slightly raise equity while AVGO is negative at -37.50%. John Neff sees competitor possibly preserving share count or buying back shares.
-13.17%
Both yoy lines negative, with AVGO at -30.00%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.